Author

M. D. Onken

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

J. A. Cooper· 2 shared A. J. Dixon· 1 shared C. M. Makepeace· 1 shared C. M. Yuede· 1 shared J. Choi· 1 shared K. D. Piggott· 1 shared K. J. Blumer· 1 shared K. M. Kaltenbronn· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. A. Cooper

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeting primary and metastatic uveal melanoma with a G protein inhibitor

M. D. Onken, C. M. Makepeace, K. M. Kaltenbronn, J. Choi, L. Hernandez-Aya, K. N. Weilbaecher, K. D. Piggott, P. K. Rao, C. M. Yuede, A. J. Dixon, P. Osei-Owusu, J. A. Cooper, K. J. Blumer

This study evaluates the therapeutic potential of FR, a Gq/11 inhibitor, in uveal melanoma by testing its effects on tumor growth, apoptosis, and metastasis in cell lines and xenograft models.

bioRxiv · Jan 16, 2021 · PreprintCancer Biology

Uveal melanoma cells use ameboid and mesenchymal mechanisms of cell motility crossing the endothelium

M. D. Onken, J. A. Cooper

This study identifies ameboid and mesenchymal motility mechanisms in uveal melanoma cells that facilitate transendothelial migration, with Gq/11 and BAP1 pathways playing key regulatory roles.

bioRxiv · Mar 18, 2020Cell Biology